CMTA_2016_Annual_Report
The Fall 2021 CMTA Report
…out walking, riding and swimming to raise money for CMTA-STAR research—everything from the Bucks County annual picnic to the daylong extravaganzas mounted by the Vermont Cycle (and Walk!) 4 CMT…
CMTA Spring 2024 Report: Progress and Impact that Empowers Communities
…webinars, local meetings, and a Patient and Research Summit. Sue expresses gratitude to the community for their courage, resilience, and commitment. The CMTA’s community-led outreach efforts in 2023 included successful…
CMTA Announces Addition of Health Insurance Industry Veteran Wendy Arnone to the Board of Directors
The Charcot-Marie-Tooth Association (CMTA), the largest philanthropic funder of Charcot-Marie-Tooth disease (CMT) research aimed at bringing treatments and a cure to patients, is pleased to announce the appointment of health…
CMTA-STAR Partner Applied Therapeutics Presents 24-Month CMT-SORD Data at PNS 2025
The Charcot-Marie-Tooth Association (CMTA) congratulates CMTA Strategy To Accelerate Research (CMTA-STAR) Alliance Partner Applied Therapeutics on presenting new 24-month results from its Phase III CMT-SORD clinical trial at the 2025…
CMTA Lunch & Learn: Neuro-Toxic Medication List Update
07/13/2023 @ 12:00 pm – 1:00 pm – Please join us on July 13 at 12:00 p.m. Eastern Time to hear an update on the newly reviewed and revised CMT Neuro-toxic Medication List. The CMTA funded a grant awarded to Guido Cavaletti, MD at the University of Milano-Bicocca to review and update the current CMT neuro-toxic medication list. Dr. Cavaletti and colleague, Dr. […]
CMTA Volunteer Spotlight
…that the best way to live with CMT is by working to raise awareness, help fund research and create community with other CMTers. My most treasured volunteer role is with…
Type 2 Update: One Patient’s Diagnostic Odyssey with SORD
…scholar from University College of London— discovered the SORD mutation “hidden” from the gene analysis software that most researchers use. Using a different strategy, the researchers found the relevant variations…
From Gene Discovery to Gene Editing: Closing the Diagnostic Gap and Developing CRISPR/Cas9 Capabilities in CMT
…with the Inherited Neuropathies Consortium (INC), researchers at the University of Miami, led by CMTA Strategy To Accelerate Research (STAR) Board member Stephan Zuchner, MD, PhD, are working to solve…
CMTA Announces New Center of Excellence in Thailand
…receiving her training from leading CMT specialist Michael Shy, MD, at the University of Iowa, she became interested in clinical research with children living with CMT. Her recent research includes…